Alemtuzumab is a monoclonal antibody. It flags the cancer cells for destruction by the body's immune system. It also modulates the immune system to limit its attacks on the nervous system.
Common side effects of Alemtuzumab
Rash, Headache, Insomnia (difficulty in sleeping), Nausea, Upper respiratory tract infection, Decreased white blood cell count, Fatigue, Fever, Itching, Flushing (sense of warmth in the face, ears, neck and trunk), Hives, Decreased white blood cell count (lymphocytes)
Reviewed By Dr. Rajeev Sharma